Abstract
High-frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex has been clearly reported to be effective in the treatment of depression. We report a patient with treatment-resistant depression, without any known risk factors, who developed seizure during the fourth rTMS session. After written informed consent, he received further rTMS sessions under cover of antiepileptic drug valproate and improved without recurrence of seizure.
| Original language | English |
|---|---|
| Pages (from-to) | 60-61 |
| Number of pages | 2 |
| Journal | Journal of ECT |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 01-03-2012 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Neuroscience (miscellaneous)
- Psychiatry and Mental health
Cite this
}
Repetitive transcranial magnetic stimulation safely administered after seizure. / Bagati, Dhruv; Mittal, Sunil; Praharaj, Samir Kumar; Sarcar, Manish; Kakra, Minal; Kumar, Pankaj.
In: Journal of ECT, Vol. 28, No. 1, 01.03.2012, p. 60-61.Research output: Contribution to journal › Article
TY - JOUR
T1 - Repetitive transcranial magnetic stimulation safely administered after seizure
AU - Bagati, Dhruv
AU - Mittal, Sunil
AU - Praharaj, Samir Kumar
AU - Sarcar, Manish
AU - Kakra, Minal
AU - Kumar, Pankaj
PY - 2012/3/1
Y1 - 2012/3/1
N2 - High-frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex has been clearly reported to be effective in the treatment of depression. We report a patient with treatment-resistant depression, without any known risk factors, who developed seizure during the fourth rTMS session. After written informed consent, he received further rTMS sessions under cover of antiepileptic drug valproate and improved without recurrence of seizure.
AB - High-frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex has been clearly reported to be effective in the treatment of depression. We report a patient with treatment-resistant depression, without any known risk factors, who developed seizure during the fourth rTMS session. After written informed consent, he received further rTMS sessions under cover of antiepileptic drug valproate and improved without recurrence of seizure.
UR - http://www.scopus.com/inward/record.url?scp=84857863326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857863326&partnerID=8YFLogxK
U2 - 10.1097/YCT.0b013e318221f9b1
DO - 10.1097/YCT.0b013e318221f9b1
M3 - Article
VL - 28
SP - 60
EP - 61
JO - Journal of ECT
JF - Journal of ECT
SN - 1095-0680
IS - 1
ER -